Showing 1931-1940 of 6037 results for "".
- SIFI Appoints Jelle Kleijn to Lead Effort to Deliver First Registered Treatment of Acanthamoeba Keratitishttps://modernod.com/news/sifi-appoints-jelle-kleijn-to-lead-effort-to-deliver-first-registered-treatment-of-acanthamoeba-keratitis/2478631/SIFI has announced the recent appointment of Jelle Kleijn, PhD, as Global Head of Acanthamoeba keratitis. Dr. Kleijn will lead the efforts aimed at developing and making polihexanide monotherapy available to Acanthamoeba keratitis (AK) patients. Given the urgency to effectively treat AK to
- Vision Impairment Tied to Less Use of Cancer Screenings by Older Adultshttps://modernod.com/news/vision-impairment-tied-to-less-use-of-cancer-screenings-by-older-adults/2478491/Older adults with vision impairment are less likely to receive recommended breast and colon cancer screenings than peers without vision problems, a U.S. study suggests, according to a Reuters report. Researchers examined data from
- Concerns Over Surgical Waste Are Clouding Future of Single-Use Device Markethttps://modernod.com/news/concerns-over-surgical-waste-are-clouding-future-of-single-use-device-market/2478423/The global single-use surgical device market has shown steady growth over several decades, reaching a peak of $3.4 billion in 2019, but growing concerns over the amount of waste created by disposable surgical devices have raised questions about future growth prospects, according to a Market Scope
- Dell, HP, Lenovo and Acer to Announce New Eyesafe Products at the Blue Light Summit 2020https://modernod.com/news/dell-hp-lenovo-and-acer-to-announce-new-eyesafe-products-at-the-blue-light-summit-2020/2478378/Eyesafe, UnitedHealthcare Vision, and TÜV Rheinland Group announced the dates and registration details as well as the initial lineup of companies and thought leaders participating in the Blue Light Summit 2020. This year’s event will be held on Oct. 15, 2020. D
- UH Professor Developing New Technology to Detect Lens Elasticity Associated With Presbyopiahttps://modernod.com/news/uh-professor-developing-new-technology-to-detect-lens-elasticity-associated-with-presbyopia/2478372/A University of Houston biomedical researcher is developing new technology that will measure the stiffness of the lens in the eye, which is likely associated with presbyopia. Presbyopia is linked to a stiffening of the crystalline lens. There are currently several invest
- Researchers Capture Cell-Level Details of Curved Corneahttps://modernod.com/news/researchers-capture-cell-level-details-of-curved-cornea/2478069/Researchers have, for the first time, acquired optical coherence tomography (OCT) images of the curved layers of a person’s cornea with cell-level detail and a large viewing area, according to a study in Optica. The new OCT instrument enables improved monitoring of eye diseases as well a
- UK Surpasses Italy In Recorded Coronavirus Deaths, Now Leads Europe In Fatalitieshttps://modernod.com/news/uk-surpasses-italy-in-recorded-coronavirus-deaths-now-leads-europe-in-fatalities/2477715/Over 32,000 people have died from the new coronavirus in the United Kingdom, according to the Office for National Statistics, marking the first time in the pandemic that it has led Europe in the number of deaths, according to an NPR
- Mojo Vision Raises Additional $51 Million to Develop Smart Contact Lenshttps://modernod.com/news/mojo-vision-raises-additional-51-million-to-develop-smart-contact-lens/2477678/Mojo Vision announced it has raised more than $51 million in a Series B-1 investment round to propel the development of its smart contact lens, Mojo Lens. This new round brings Mojo Vision’s total funding to date to more than $159 million. In January, Mojo announced that it is in th
- US Department of Labor Provides Guidance on Paid Sick and Family Leavehttps://modernod.com/news/us-department-of-labor-provides-guidance-on-paid-sick-and-family-leave/2477487/The Department of Labor just updated its ‘Questions and Answers’ on paid sick and family leave during the COVID-19 pandemic. This includes guidance on: (i) teleworking, furloughs, layoffs, reduced schedules, and office closures (employees are not eligible for paid sick o
- Analysis: FDA’s Efforts to Speed Drug Approval May Have Led to Less Rigorous Clinical Outcome Requirementshttps://modernod.com/news/analysis-fdas-efforts-to-speed-drug-approval-may-have-led-to-less-rigorous-clinical-outcome-requirements/2477231/An analysis published in JAMA suggests that efforts by the FDA to speed the development and approval of drugs may have led to a reduction in the amount of evidence available at the time of authorization by the agency and an increase in more surrogate measures. However, the authors noted